|
FDA Warns Trial Investigator for IRB, Consent Form, Protocol Violations
The FDA has handed a cardiac surgeon at Washington, D.C.-based Washington Hospital Center a warning letter for not having institutional review board (IRB) approval when recruiting some patients into a clinical trial.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives